Home › Companies › Collegium Pharmaceutical, Inc. › 2024-2025

Collegium Pharmaceutical, Inc. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and Collegium Pharmaceutical, Inc.’s Form 8-K, filed May 19, 2025 (Item 5.07 on EDGAR). Page generated October 25, 2026.

  • 20Reported items
  • 282Asset managers
  • 3,931Fund votes
  • May 15, 2025Meeting date

Results at a glance

Meeting of May 15, 2025: 11 items on Collegium Pharmaceutical, Inc.’s Form 8-K, filed May 19, 2025: 7 elected · 3 approved · 1 without a stated outcome.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Collegium Pharmaceutical, Inc. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by Collegium Pharmaceutical, Inc.

These tallies are Collegium Pharmaceutical, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 19, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Collegium Pharmaceutical, Inc. — official shareholder meeting results, meeting held May 15, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Rita Balice-Gordon 24,842,387251,8452,550,989 --1,449,301 99%Not verified—
Elect Director: Garen Bohlin 24,980,953127,5222,536,746 --1,449,301 99.4%Elected—
Elect Director: John Fallon 24,314,536793,4002,537,285 --1,449,301 97%Elected—
Elect Director: John Freund 24,494,346614,3732,536,502 --1,449,301 98%Elected—
Elect Director: Vikram Karnani 25,001,176107,4102,536,635 --1,449,301 99.5%Elected—
Elect Director: Nancy Lurker 25,089,51418,9822,536,725 --1,449,301 99.9%Elected—
Elect Director: Carlos Paya 25,074,33921,9382,548,944 --1,449,301 99.9%Elected—
Elect Director: Gino Santini 24,829,920278,6552,536,646 --1,449,301 99%Elected—
2. Approval of, on an advisory basis, the compensation of the Company's named executive officers 22,867,4142,233,5412,544,266 --1,449,301 91%Approved—
4. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 28,706,712141,452246,358 --0 99.5%Approved—
5. Approval of the Collegium Pharmaceutical, Inc 20,255,7837,143,482245,956 --1,449,301 74%Approved—

Source: Collegium Pharmaceutical, Inc., Form 8-K, filed with the SEC on May 19, 2025 — read the filing on EDGAR.

How asset managers voted at the Collegium Pharmaceutical, Inc. 2024-2025 meeting

Each item below shows how the 282 asset managers that disclosed a Collegium Pharmaceutical, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Collegium Pharmaceutical, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani…: Carlos Paya

No official matchDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 59 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: Carlos Paya

The 59 asset managers below reported 12,232,590 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 12,232,590
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nanc” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST2,629,5930 00For
Vanguard2,168,9150 00For
Capitol Series Trust1,305,8640 00For
Invesco941,3380 00For
Principal810,9960 00For
Dimensional750,8640 00For
Fidelity724,2550 00For
MFS628,2450 00For
State Street418,8160 00For
Royce295,6810 00For
Victory Capital195,1110 00For
Pacific Life95,7650 00For
MassMutual92,9590 00For
Equitable92,8490 00For
American Century89,5330 00For
TIAA87,8480 00For
AMERICAN BEACON FUNDS75,9800 00For
Columbia Threadneedle67,9680 00For
Janus Detroit Street Trust67,3090 00For
EXCHANGE TRADED CONCEPTS TRUST62,3040 00For
Goldman Sachs51,3460 00For
WisdomTree49,8740 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC45,3000 00For
Lincoln Financial45,2400 00For
First Trust42,8550 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

2. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram…: Garen Bohlin

No official matchDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 59 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: Garen Bohlin

The 59 asset managers below reported 12,232,590 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 12,232,590
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nanc” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST2,629,5930 00For
Vanguard2,168,9150 00For
Capitol Series Trust1,305,8640 00For
Invesco941,3380 00For
Principal810,9960 00For
Dimensional750,8640 00For
Fidelity724,2550 00For
MFS628,2450 00For
State Street418,8160 00For
Royce295,6810 00For
Victory Capital195,1110 00For
Pacific Life95,7650 00For
MassMutual92,9590 00For
Equitable92,8490 00For
American Century89,5330 00For
TIAA87,8480 00For
AMERICAN BEACON FUNDS75,9800 00For
Columbia Threadneedle67,9680 00For
Janus Detroit Street Trust67,3090 00For
EXCHANGE TRADED CONCEPTS TRUST62,3040 00For
Goldman Sachs51,3460 00For
WisdomTree49,8740 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC45,3000 00For
Lincoln Financial45,2400 00For
First Trust42,8550 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

3. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram…: Gino Santini

No official matchDIRECTOR ELECTIONS

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 59 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: Gino Santini

The 59 asset managers below reported 12,229,154 for, 3,436 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 12,229,154AGAINST: 3,436
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nanc” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST2,629,5930 00For
Vanguard2,168,9150 00For
Capitol Series Trust1,305,8640 00For
Invesco941,3380 00For
Principal810,9960 00For
Dimensional750,8640 00For
Fidelity724,2550 00For
MFS628,2450 00For
State Street418,79917 00For
Royce295,6810 00For
Victory Capital195,1110 00For
Pacific Life95,7650 00For
MassMutual92,9590 00For
Equitable92,8490 00For
American Century89,5330 00For
TIAA87,8480 00For
AMERICAN BEACON FUNDS75,9800 00For
Columbia Threadneedle67,9680 00For
Janus Detroit Street Trust67,3090 00For
EXCHANGE TRADED CONCEPTS TRUST62,3040 00For
Goldman Sachs51,3460 00For
WisdomTree49,8740 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC45,3000 00For
Lincoln Financial45,2400 00For
First Trust42,8550 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

4. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram…: John Fallon, M.D.

No official matchDIRECTOR ELECTIONS

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 59 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: John Fallon, M.D.

The 59 asset managers below reported 12,229,171 for, 3,419 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 12,229,171AGAINST: 3,419
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nanc” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST2,629,5930 00For
Vanguard2,168,9150 00For
Capitol Series Trust1,305,8640 00For
Invesco941,3380 00For
Principal810,9960 00For
Dimensional750,8640 00For
Fidelity724,2550 00For
MFS628,2450 00For
State Street418,8160 00For
Royce295,6810 00For
Victory Capital195,1110 00For
Pacific Life95,7650 00For
MassMutual92,9590 00For
Equitable92,8490 00For
American Century89,5330 00For
TIAA87,8480 00For
AMERICAN BEACON FUNDS75,9800 00For
Columbia Threadneedle67,9680 00For
Janus Detroit Street Trust67,3090 00For
EXCHANGE TRADED CONCEPTS TRUST62,3040 00For
Goldman Sachs51,3460 00For
WisdomTree49,8740 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC45,3000 00For
Lincoln Financial45,2400 00For
First Trust42,8550 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

5. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram…: John Freund, M.D.

No official matchDIRECTOR ELECTIONS

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 59 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: John Freund, M.D.

The 59 asset managers below reported 12,232,573 for, 17 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 12,232,573AGAINST: 17
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nanc” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST2,629,5930 00For
Vanguard2,168,9150 00For
Capitol Series Trust1,305,8640 00For
Invesco941,3380 00For
Principal810,9960 00For
Dimensional750,8640 00For
Fidelity724,2550 00For
MFS628,2450 00For
State Street418,79917 00For
Royce295,6810 00For
Victory Capital195,1110 00For
Pacific Life95,7650 00For
MassMutual92,9590 00For
Equitable92,8490 00For
American Century89,5330 00For
TIAA87,8480 00For
AMERICAN BEACON FUNDS75,9800 00For
Columbia Threadneedle67,9680 00For
Janus Detroit Street Trust67,3090 00For
EXCHANGE TRADED CONCEPTS TRUST62,3040 00For
Goldman Sachs51,3460 00For
WisdomTree49,8740 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC45,3000 00For
Lincoln Financial45,2400 00For
First Trust42,8550 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

6. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram…: Nancy Lurker

No official matchDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 59 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: Nancy Lurker

The 59 asset managers below reported 12,232,590 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 12,232,590
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nanc” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST2,629,5930 00For
Vanguard2,168,9150 00For
Capitol Series Trust1,305,8640 00For
Invesco941,3380 00For
Principal810,9960 00For
Dimensional750,8640 00For
Fidelity724,2550 00For
MFS628,2450 00For
State Street418,8160 00For
Royce295,6810 00For
Victory Capital195,1110 00For
Pacific Life95,7650 00For
MassMutual92,9590 00For
Equitable92,8490 00For
American Century89,5330 00For
TIAA87,8480 00For
AMERICAN BEACON FUNDS75,9800 00For
Columbia Threadneedle67,9680 00For
Janus Detroit Street Trust67,3090 00For
EXCHANGE TRADED CONCEPTS TRUST62,3040 00For
Goldman Sachs51,3460 00For
WisdomTree49,8740 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC45,3000 00For
Lincoln Financial45,2400 00For
First Trust42,8550 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

7. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D…: Rita Balice-Gordon, Ph.D.

No official matchDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 59 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: Rita Balice-Gordon, Ph.D.

The 59 asset managers below reported 12,232,590 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 12,232,590
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nanc” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST2,629,5930 00For
Vanguard2,168,9150 00For
Capitol Series Trust1,305,8640 00For
Invesco941,3380 00For
Principal810,9960 00For
Dimensional750,8640 00For
Fidelity724,2550 00For
MFS628,2450 00For
State Street418,8160 00For
Royce295,6810 00For
Victory Capital195,1110 00For
Pacific Life95,7650 00For
MassMutual92,9590 00For
Equitable92,8490 00For
American Century89,5330 00For
TIAA87,8480 00For
AMERICAN BEACON FUNDS75,9800 00For
Columbia Threadneedle67,9680 00For
Janus Detroit Street Trust67,3090 00For
EXCHANGE TRADED CONCEPTS TRUST62,3040 00For
Goldman Sachs51,3460 00For
WisdomTree49,8740 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC45,3000 00For
Lincoln Financial45,2400 00For
First Trust42,8550 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

8. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram…: Vikram Karnani

No official matchDIRECTOR ELECTIONS

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 59 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: Vikram Karnani

The 59 asset managers below reported 12,232,578 for, 12 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 12,232,578AGAINST: 12
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nanc” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST2,629,5930 00For
Vanguard2,168,9150 00For
Capitol Series Trust1,305,8640 00For
Invesco941,3380 00For
Principal810,9960 00For
Dimensional750,8640 00For
Fidelity724,2550 00For
MFS628,2450 00For
State Street418,80412 00For
Royce295,6810 00For
Victory Capital195,1110 00For
Pacific Life95,7650 00For
MassMutual92,9590 00For
Equitable92,8490 00For
American Century89,5330 00For
TIAA87,8480 00For
AMERICAN BEACON FUNDS75,9800 00For
Columbia Threadneedle67,9680 00For
Janus Detroit Street Trust67,3090 00For
EXCHANGE TRADED CONCEPTS TRUST62,3040 00For
Goldman Sachs51,3460 00For
WisdomTree49,8740 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC45,3000 00For
Lincoln Financial45,2400 00For
First Trust42,8550 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

9. Elect Director: Carlos Paya

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 25,074,339AGAINST: 21,938
Details: description as filed, official tally, votes by 38 asset managers

Description as filed by funds: Election of Director to hold office until the 2026 Annual Meeting: Carlos Paya

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Carlos Paya”): 25,074,339 for, 21,938 against, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, John Fallon, John Freund, Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini was elected by the Company's shareholders as Directors to hold office until the 2026 Annual Meeting of Shareholders.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 38 asset managers below reported 4,986,079 for, 0 against, 6,913 abstained.

FOR
FOR: 4,986,079AGAINST: 0ABSTAIN: 6,913
Largest asset managers voting on “Election of Director to hold office until the 2026 Annual Meeting: Carlos Paya” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock2,870,1910 00For
Pacer Funds Trust416,9440 00For
Charles Schwab321,0190 00For
SEI299,2360 00For
FINANCIAL INVESTORS TRUST284,6310 00For
THIRD AVENUE TRUST203,0080 00For
World Funds Trust165,2080 00For
RBB FUND, INC.79,5910 00For
Jackson National64,4110 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
JPMorgan40,0880 00For
SEI Exchange Traded Funds28,2170 00For
Empower25,3840 00For
Loomis Sayles25,2270 00For
Harbor ETF Trust20,5680 00For
Global X19,0260 00For
ETF Series Solutions15,9250 00For
Allianz11,6150 00For
John Hancock11,4740 00For
Brighthouse00 6,9090Abstain
Bridge Builder Trust6,2590 00For
GPS Funds I4,5930 00For
Vanguard3,9800 40For
Tidal Trust III3,2950 00For
Prudential/PGIM2,9190 00For

Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.

10. Elect Director: Garen Bohlin

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 24,980,953AGAINST: 127,522
Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: Election of Director to hold office until the 2026 Annual Meeting: Garen Bohlin

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Garen Bohlin”): 24,980,953 for, 127,522 against, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, John Fallon, John Freund, Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini was elected by the Company's shareholders as Directors to hold office until the 2026 Annual Meeting of Shareholders.”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 4,969,319 for, 16,055 against, 6,913 abstained.

FOR
FOR: 4,969,319AGAINST: 16,055ABSTAIN: 6,913
Largest asset managers voting on “Election of Director to hold office until the 2026 Annual Meeting: Garen Bohlin” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock2,870,1910 00For
Pacer Funds Trust416,9440 00For
Charles Schwab321,0190 00For
SEI299,2360 00For
FINANCIAL INVESTORS TRUST284,6310 00For
THIRD AVENUE TRUST203,0080 00For
World Funds Trust165,2080 00For
RBB FUND, INC.79,5910 00For
Jackson National64,4110 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
JPMorgan40,0880 00For
SEI Exchange Traded Funds28,2170 00For
Empower25,3840 00For
Loomis Sayles25,2270 00For
Harbor ETF Trust20,5680 00For
Global X19,0260 00For
ETF Series Solutions015,925 00Against
Allianz11,6150 00For
John Hancock11,4740 00For
Brighthouse00 6,9090Abstain
Bridge Builder Trust6,2590 00For
GPS Funds I4,5930 00For
Vanguard3,9800 40For
Tidal Trust III3,2950 00For
Prudential/PGIM2,9190 00For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

11. Elect Director: Gino Santini

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 24,829,920AGAINST: 278,655
Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: Election of Director to hold office until the 2026 Annual Meeting: Gino Santini

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Gino Santini”): 24,829,920 for, 278,655 against, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, John Fallon, John Freund, Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini was elected by the Company's shareholders as Directors to hold office until the 2026 Annual Meeting of Shareholders.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 4,966,495 for, 18,879 against, 6,913 abstained.

FOR
FOR: 4,966,495AGAINST: 18,879ABSTAIN: 6,913
Largest asset managers voting on “Election of Director to hold office until the 2026 Annual Meeting: Gino Santini” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock2,870,1910 00For
Pacer Funds Trust416,9440 00For
Charles Schwab321,0190 00For
SEI299,2360 00For
FINANCIAL INVESTORS TRUST284,6310 00For
THIRD AVENUE TRUST203,0080 00For
World Funds Trust165,2080 00For
RBB FUND, INC.79,5910 00For
Jackson National64,4110 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
JPMorgan40,0880 00For
SEI Exchange Traded Funds28,2170 00For
Empower25,3840 00For
Loomis Sayles25,2270 00For
Harbor ETF Trust20,5680 00For
Global X19,0260 00For
ETF Series Solutions015,925 00Against
Allianz11,6150 00For
John Hancock11,4740 00For
Brighthouse00 6,9090Abstain
Bridge Builder Trust6,2590 00For
GPS Funds I4,5930 00For
Vanguard3,9800 40For
Tidal Trust III3,2950 00For
Prudential/PGIM2,9190 00For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

12. Elect Director: John Fallon

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 24,314,536AGAINST: 793,400
Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: Election of Director to hold office until the 2026 Annual Meeting: John Fallon, M.D.

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: John Fallon”): 24,314,536 for, 793,400 against, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, John Fallon, John Freund, Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini was elected by the Company's shareholders as Directors to hold office until the 2026 Annual Meeting of Shareholders.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 4,982,549 for, 2,825 against, 6,913 abstained.

FOR
FOR: 4,982,549AGAINST: 2,825ABSTAIN: 6,913
Largest asset managers voting on “Election of Director to hold office until the 2026 Annual Meeting: John Fallon, M.D.” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock2,870,1910 00For
Pacer Funds Trust416,9440 00For
Charles Schwab321,0190 00For
SEI299,2360 00For
FINANCIAL INVESTORS TRUST284,6310 00For
THIRD AVENUE TRUST203,0080 00For
World Funds Trust165,2080 00For
RBB FUND, INC.79,5910 00For
Jackson National64,4110 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
JPMorgan40,0880 00For
SEI Exchange Traded Funds28,2170 00For
Empower25,3840 00For
Loomis Sayles25,2270 00For
Harbor ETF Trust20,5680 00For
Global X19,0260 00For
ETF Series Solutions15,9250 00For
Allianz11,6150 00For
John Hancock11,4740 00For
Brighthouse00 6,9090Abstain
Bridge Builder Trust6,2590 00For
GPS Funds I4,5930 00For
Vanguard3,9791 40For
Tidal Trust III3,2950 00For
Prudential/PGIM2,9190 00For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

13. Elect Director: John Freund

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 24,494,346AGAINST: 614,373
Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: Election of Director to hold office until the 2026 Annual Meeting: John Freund, M.D.

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: John Freund”): 24,494,346 for, 614,373 against, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, John Fallon, John Freund, Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini was elected by the Company's shareholders as Directors to hold office until the 2026 Annual Meeting of Shareholders.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 4,966,494 for, 18,880 against, 6,913 abstained.

FOR
FOR: 4,966,494AGAINST: 18,880ABSTAIN: 6,913
Largest asset managers voting on “Election of Director to hold office until the 2026 Annual Meeting: John Freund, M.D.” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock2,870,1910 00For
Pacer Funds Trust416,9440 00For
Charles Schwab321,0190 00For
SEI299,2360 00For
FINANCIAL INVESTORS TRUST284,6310 00For
THIRD AVENUE TRUST203,0080 00For
World Funds Trust165,2080 00For
RBB FUND, INC.79,5910 00For
Jackson National64,4110 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
JPMorgan40,0880 00For
SEI Exchange Traded Funds28,2170 00For
Empower25,3840 00For
Loomis Sayles25,2270 00For
Harbor ETF Trust20,5680 00For
Global X19,0260 00For
ETF Series Solutions015,925 00Against
Allianz11,6150 00For
John Hancock11,4740 00For
Brighthouse00 6,9090Abstain
Bridge Builder Trust6,2590 00For
GPS Funds I4,5930 00For
Vanguard3,9791 40For
Tidal Trust III3,2950 00For
Prudential/PGIM2,9190 00For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

14. Elect Director: Nancy Lurker

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 25,089,514AGAINST: 18,982
Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: Election of Director to hold office until the 2026 Annual Meeting: Nancy Lurker

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Nancy Lurker”): 25,089,514 for, 18,982 against, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, John Fallon, John Freund, Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini was elected by the Company's shareholders as Directors to hold office until the 2026 Annual Meeting of Shareholders.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 4,985,374 for, 0 against, 6,913 abstained.

FOR
FOR: 4,985,374AGAINST: 0ABSTAIN: 6,913
Largest asset managers voting on “Election of Director to hold office until the 2026 Annual Meeting: Nancy Lurker” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock2,870,1910 00For
Pacer Funds Trust416,9440 00For
Charles Schwab321,0190 00For
SEI299,2360 00For
FINANCIAL INVESTORS TRUST284,6310 00For
THIRD AVENUE TRUST203,0080 00For
World Funds Trust165,2080 00For
RBB FUND, INC.79,5910 00For
Jackson National64,4110 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
JPMorgan40,0880 00For
SEI Exchange Traded Funds28,2170 00For
Empower25,3840 00For
Loomis Sayles25,2270 00For
Harbor ETF Trust20,5680 00For
Global X19,0260 00For
ETF Series Solutions15,9250 00For
Allianz11,6150 00For
John Hancock11,4740 00For
Brighthouse00 6,9090Abstain
Bridge Builder Trust6,2590 00For
GPS Funds I4,5930 00For
Vanguard3,9800 40For
Tidal Trust III3,2950 00For
Prudential/PGIM2,9190 00For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

15. Elect Director: Rita Balice-Gordon

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 24,842,387AGAINST: 251,845
Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: Election of Director to hold office until the 2026 Annual Meeting: Rita Balice-Gordon, Ph.D.

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Rita Balice-Gordon”): 24,842,387 for, 251,845 against, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 4,982,550 for, 2,824 against, 6,913 abstained.

FOR
FOR: 4,982,550AGAINST: 2,824ABSTAIN: 6,913
Largest asset managers voting on “Election of Director to hold office until the 2026 Annual Meeting: Rita Balice-Gordon, Ph.D.” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock2,870,1910 00For
Pacer Funds Trust416,9440 00For
Charles Schwab321,0190 00For
SEI299,2360 00For
FINANCIAL INVESTORS TRUST284,6310 00For
THIRD AVENUE TRUST203,0080 00For
World Funds Trust165,2080 00For
RBB FUND, INC.79,5910 00For
Jackson National64,4110 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
JPMorgan40,0880 00For
SEI Exchange Traded Funds28,2170 00For
Empower25,3840 00For
Loomis Sayles25,2270 00For
Harbor ETF Trust20,5680 00For
Global X19,0260 00For
ETF Series Solutions15,9250 00For
Allianz11,6150 00For
John Hancock11,4740 00For
Brighthouse00 6,9090Abstain
Bridge Builder Trust6,2590 00For
GPS Funds I4,5930 00For
Vanguard3,9800 40For
Tidal Trust III3,2950 00For
Prudential/PGIM2,9190 00For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

16. Elect Director: Vikram Karnani

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 25,001,176AGAINST: 107,410
Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: Election of Director to hold office until the 2026 Annual Meeting: Vikram Karnani

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Vikram Karnani”): 25,001,176 for, 107,410 against, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, John Fallon, John Freund, Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini was elected by the Company's shareholders as Directors to hold office until the 2026 Annual Meeting of Shareholders.”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 4,985,374 for, 0 against, 6,913 abstained.

FOR
FOR: 4,985,374AGAINST: 0ABSTAIN: 6,913
Largest asset managers voting on “Election of Director to hold office until the 2026 Annual Meeting: Vikram Karnani” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock2,870,1910 00For
Pacer Funds Trust416,9440 00For
Charles Schwab321,0190 00For
SEI299,2360 00For
FINANCIAL INVESTORS TRUST284,6310 00For
THIRD AVENUE TRUST203,0080 00For
World Funds Trust165,2080 00For
RBB FUND, INC.79,5910 00For
Jackson National64,4110 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
JPMorgan40,0880 00For
SEI Exchange Traded Funds28,2170 00For
Empower25,3840 00For
Loomis Sayles25,2270 00For
Harbor ETF Trust20,5680 00For
Global X19,0260 00For
ETF Series Solutions15,9250 00For
Allianz11,6150 00For
John Hancock11,4740 00For
Brighthouse00 6,9090Abstain
Bridge Builder Trust6,2590 00For
GPS Funds I4,5930 00For
Vanguard3,9800 40For
Tidal Trust III3,2950 00For
Prudential/PGIM2,9190 00For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

17. 5. Approval of the Collegium Pharmaceutical, Inc

Official resultFund totals may overlapCOMPENSATIONReported outcome: Approved

74% Approved · of votes cast

FOR 74%AGAINST
FOR: 20,255,783AGAINST: 7,143,482
Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: To approve the Collegium Pharmaceutical, Inc. 2025 Equity Incentive Plan

Collegium Pharmaceutical, Inc.’s own tally for this item (“5. Approval of the Collegium Pharmaceutical, Inc”): 20,255,783 for, 7,143,482 against — passed, per its Form 8-K filed May 19, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 5: Approval of the Collegium Pharmaceutical, Inc”
Support: 74% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 88 asset managers voting on “To approve the Collegium Pharmaceutical, Inc. 2025 Equity Incentive Plan” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock2,870,1910 00For
MUTUAL FUND SERIES TRUST2,629,5930 00For
Vanguard2,172,88613 00For
Capitol Series Trust01,305,864 00Against
Invesco941,3380 00For
Principal810,9960 00For
Dimensional0750,864 00Against
Fidelity724,2550 00For
MFS628,2450 00For
State Street408,73310,083 00For
Pacer Funds Trust0416,944 00Against
Charles Schwab321,0190 00For
SEI299,2360 00For
Royce0295,681 00Against
FINANCIAL INVESTORS TRUST284,6310 00For
THIRD AVENUE TRUST203,0080 00For
Victory Capital0195,111 00Against
World Funds Trust0165,208 00Against
Pacific Life95,7650 00For
MassMutual92,9590 00For
Equitable92,8490 00For
American Century089,533 00Against
TIAA87,8480 00For
RBB FUND, INC.79,5910 00For
AMERICAN BEACON FUNDS075,980 00Against

Fund voting reports, all 88 managers: 13,419,246 for, 3,774,292 against, 1,800 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 4 asset managers voting on “To approve the Collegium Pharmaceutical, Inc. 2025 Equity Incentive Plan” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Quantedge Capital Pte Ltd00 234,8550Abstain
Jackson Creek Investment Advisors LLC1,3310 00For
UNITED CAPITAL FINANCIAL ADVISORS, LLC0114 00Against
Boltwood Capital Management340 00For

Institutional-manager reports, all 4 managers: 1,365 for, 114 against, 234,855 abstained.

18. 2. Approval of, on an advisory basis, the compensation of the Company's named executive officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 10 wordings of this item as funds reported it.

91% Approved · of votes cast

FOR 91%
FOR: 22,867,414AGAINST: 2,233,541
Details: description as filed, official tally, votes by 282 asset managers

Description as filed by funds: Approval of, on an advisory basis, the compensation of the Company's named executive officers

Collegium Pharmaceutical, Inc.’s own tally for this item (“2. Approval of, on an advisory basis, the compensation of the Company's named executive officers”): 22,867,414 for, 2,233,541 against — passed, per its Form 8-K filed May 19, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “On an advisory basis, the Company's shareholders approved the compensation of the Company's named executive officers.”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 91 asset managers voting on “Approval of, on an advisory basis, the compensation of the Company's named executive officers” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock2,870,1910 00For
MUTUAL FUND SERIES TRUST2,629,5930 00For
Vanguard2,171,0021,893 40For
Capitol Series Trust1,305,8640 00For
Invesco0941,338 00Against
Principal810,9960 00For
Dimensional750,8640 00For
Fidelity724,2550 00For
MFS628,2450 00For
State Street418,478338 00For
Pacer Funds Trust416,9440 00For
Charles Schwab321,0190 00For
SEI299,2360 00For
Royce295,6810 00For
FINANCIAL INVESTORS TRUST284,6310 00For
THIRD AVENUE TRUST203,0080 00For
Victory Capital195,1110 00For
World Funds Trust165,2080 00For
Pacific Life95,7650 00For
MassMutual092,959 00Against
Equitable92,8490 00For
American Century089,533 00Against
TIAA87,8480 00For
RBB FUND, INC.87,5460 00For
AMERICAN BEACON FUNDS75,9800 00For

Fund voting reports, all 91 managers: 16,003,915 for, 1,236,785 against, 6,913 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 218 asset managers voting on “Approval of, on an advisory basis, the compensation of the Company's named executive officers” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Rubric Capital Management LP00 2,290,9050Abstain
FULLER & THALER ASSET MANAGEMENT, INC.1,358,8560 00For
BlackRock1,175,7190 00For
Invesco01,170,535 00Against
State Street1,045,433338 00For
PRINCIPAL GLOBAL INVESTORS1,014,9390 00For
GEODE CAPITAL MANAGEMENT, LLC760,4930 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/713,8590 00For
Renaissance697,1380 00For
EMERALD MUTUAL FUND ADVISERS TRUST573,3760 00For
Janus Henderson388,5750 00For
Victory Capital354,7190 00For
Charles Schwab351,5680 00For
SEI338,5930 00For
EMERALD ADVISERS, LLC334,6890 00For
Allianz0246,303 00Against
Northern Trust241,4630 00For
Quantedge Capital Pte Ltd00 234,8550Abstain
MELLON INVESTMENTS Corp172,9070 00For
Hillsdale Investment Management Inc.132,9000 00For
Vanguard110,3700 00For
Uniplan Investment Counsel, Inc.102,4520 00For
LSV ASSET MANAGEMENT99,9550 00For
Brandywine Global Investment Management, LLC96,4630 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC95,9210 00For

Institutional-manager reports, all 218 managers: 12,061,363 for, 1,830,262 against, 2,525,760 abstained, 427 not voted, 36,159 1 year. Showing the 25 largest; see all in the interactive database.

19. TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION OF THE…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 7 wordings of this item as funds reported it.

100% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: description as filed, votes by 267 asset managers

Description as filed by funds: TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 87 asset managers voting on “TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION O” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock00 00--
MUTUAL FUND SERIES TRUST00 00--
Vanguard00 00--
Invesco00 00--
Principal00 00--
Dimensional00 00--
Fidelity00 00--
MFS00 00--
State Street00 00--
Pacer Funds Trust00 00--
Charles Schwab00 00--
SEI00 00--
Royce00 00--
FINANCIAL INVESTORS TRUST00 00--
THIRD AVENUE TRUST00 00--
Victory Capital00 00--
World Funds Trust00 00--
Pacific Life00 00--
MassMutual00 00--
Equitable00 00--
American Century00 00--
TIAA00 00--
RBB FUND, INC.00 00--
AMERICAN BEACON FUNDS00 00--
Columbia Threadneedle00 00--

Fund voting reports, all 87 managers: 20,171 for, 6,909 abstained, 15,093,464 1 year, 776,885 3 year, 0 2 year. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 205 asset managers voting on “TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION O” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Rubric Capital Management LP00 00--
FULLER & THALER ASSET MANAGEMENT, INC.00 00--
BlackRock00 00--
Invesco00 00--
State Street00 00--
PRINCIPAL GLOBAL INVESTORS00 00--
GEODE CAPITAL MANAGEMENT, LLC00 00--
MASSACHUSETTS FINANCIAL SERVICES CO /MA/00 00--
Renaissance00 00--
EMERALD MUTUAL FUND ADVISERS TRUST00 00--
Janus Henderson00 00--
Victory Capital00 00--
Charles Schwab00 00Not Voted
SEI00 00--
EMERALD ADVISERS, LLC00 00--
Allianz00 00--
Northern Trust00 00--
Quantedge Capital Pte Ltd00 234,8550Abstain
MELLON INVESTMENTS Corp00 00--
Hillsdale Investment Management Inc.00 00--
Vanguard00 00--
LSV ASSET MANAGEMENT00 00--
Brandywine Global Investment Management, LLC00 00--
PARAMETRIC PORTFOLIO ASSOCIATES LLC00 00--
Loomis Sayles00 00--

Institutional-manager reports, all 205 managers: 37,444 for, 234,855 abstained, 427 not voted, 15,866,264 1 year, 119,011 3 year. Showing the 25 largest; see all in the interactive database.

20. 4. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

99.5% Approved · of votes cast

FOR 99.5%
FOR: 28,706,712AGAINST: 141,452
Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025

Collegium Pharmaceutical, Inc.’s own tally for this item (“4. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 28,706,712 for, 141,452 against — passed, per its Form 8-K filed May 19, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4 was approved by the Company's shareholders.”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 17,197,715 for, 36,365 against, 6,909 abstained.

FOR
FOR: 17,197,715AGAINST: 36,365ABSTAIN: 6,909
Largest asset managers voting on “Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accoun” at Collegium Pharmaceutical, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock2,870,1910 00For
MUTUAL FUND SERIES TRUST2,629,5930 00For
Vanguard2,172,8980 00For
Capitol Series Trust1,305,8640 00For
Invesco941,3380 00For
Principal810,9960 00For
Dimensional750,8640 00For
Fidelity724,2550 00For
MFS628,2450 00For
State Street418,79917 00For
Pacer Funds Trust416,9440 00For
Charles Schwab321,0190 00For
SEI299,2360 00For
Royce295,6810 00For
FINANCIAL INVESTORS TRUST284,6310 00For
THIRD AVENUE TRUST203,0080 00For
Victory Capital195,1110 00For
World Funds Trust165,2080 00For
Pacific Life95,7650 00For
MassMutual92,9590 00For
Equitable92,8490 00For
American Century89,5330 00For
TIAA87,8480 00For
RBB FUND, INC.79,5910 00For
AMERICAN BEACON FUNDS75,9800 00For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

Largest Collegium Pharmaceutical, Inc. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 32,131,798 shares outstanding at the time of that meeting.

Fund voting reports: top Collegium Pharmaceutical, Inc. shareholders by shares voted on “Approval of, on an advisory basis, the compensation of the Company's named executive officers”, 2024-2025
#Asset manager % of shares outstanding
1BlackRock 8.93%
2MUTUAL FUND SERIES TRUST 8.18%
3Vanguard 6.76%
4Capitol Series Trust 4.06%
5Invesco 2.93%
6Principal 2.52%
7Dimensional 2.34%
8Fidelity 2.25%
9MFS 1.96%
10State Street 1.30%
Institutional-manager reports: top Collegium Pharmaceutical, Inc. shareholders by shares voted on “Approval of, on an advisory basis, the compensation of the Company's named executive officers”, 2024-2025
#Asset manager % of shares outstanding
1Rubric Capital Management LP 7.13%
2FULLER & THALER ASSET MANAGEMENT, INC. 4.23%
3BlackRock 3.66%
4Invesco 3.64%
5State Street 3.25%
6PRINCIPAL GLOBAL INVESTORS 3.16%
7GEODE CAPITAL MANAGEMENT, LLC 2.37%
8MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 2.22%
9Renaissance 2.17%
10EMERALD MUTUAL FUND ADVISERS TRUST 1.78%

Reported Collegium Pharmaceutical, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Collegium Pharmaceutical, Inc. holdings and ownership disclosed for the 2024-2025 proxy season
Holder % outstanding Disclosure
BlackRock 16.97% 13F
BlackRock Institutional Trust Company, N.A. 15.41% DEF14A
Rubric Capital Management LP 7.31% DEF14A
Vanguard Group 6.99% 13F
Pacer Advisors, Inc. 6.67% DEF14A
Pacer US Small Cap Cash Cows ETF 6.66% 13G
JANUS HENDERSON GROUP PLC 5.68% 13G
Invesco 5.08% 13F
Renaissance Technologies 5.03% 13F
Integrated Core Strategies (US) LLC 4.72% 13G

Percentages above are of 32,131,798 shares outstanding, as reported by Collegium Pharmaceutical, Inc. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Collegium Pharmaceutical, Inc.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.

At Collegium Pharmaceutical, Inc.'s shareholder meeting held May 15, 2025, in the 2024-2025 proxy season, 282 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,931 separate fund positions. Their filings are grouped here into 20 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval of, on an advisory basis, the compensation of the Company's named executive officers — Collegium Pharmaceutical, Inc.'s filing reports the proposal as approved, with 91% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Collegium Pharmaceutical, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 19, 2025.

Collegium Pharmaceutical, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.